Antithrombotic treatment in patients with acute coronary syndromes and atrial fibrillation. What is established and what is missing

被引：2
|
作者：
Tsioufis, Costas [1 ,2 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Hippokrat Hosp, Cardiol, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Hippokrat Hosp, Cardiol Clin 1, Hellenic Soc Cardiol,Med Sch, Athens, Greece
来源：
HELLENIC JOURNAL OF CARDIOLOGY | 2018年 / 59卷 / 01期
关键词：
DUAL ANTIPLATELET THERAPY; BLEEDING RISK PATIENTS; MYOCARDIAL-INFARCTION; ORAL ANTICOAGULATION; STENT IMPLANTATION; PREVENTION; COLLABORATION; INTERVENTION; CLOPIDOGREL; ASPIRIN;
D O I：
10.1016/j.hjc.2018.04.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：66 / 67
页数：2
相关论文
共 50 条
  • [21] Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome
    Tubaro, Marco
    Falaschi, Giulia
    Colivicchi, Furio
    GIORNALE ITALIANO DI CARDIOLOGIA, 2018, 19 (10) : 552 - 562
  • [22] Stroke prevention in patients with nonvalvular atrial fibrillation. What's new?
    Lobos Bejarano, Jose M.
    Mena Gonzalez, Amparo
    ATENCION PRIMARIA, 2013, 45 : 1 - 4
  • [23] What is Established and What is New in Ablation of Persistent Atrial Fibrillation?
    Kuck, Karl-Heinz
    Metzner, Andreas
    ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2015, 4 (02) : 80 - 80
  • [24] Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting
    Wrigley, Benjamin J.
    Tapp, Luke D.
    Shantsila, Eduard
    Lip, Gregory Y. H.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2010, 120 (7-8): : 290 - 293
  • [25] Acute coronary syndromes and atrial fibrillation
    Foussas, Stefanos
    HELLENIC JOURNAL OF CARDIOLOGY, 2016, 57 (02) : 141 - 142
  • [26] Antithrombotic treatment in acute coronary syndromes
    Hoole, S. P.
    Saw, J.
    MINERVA MEDICA, 2010, 101 (04) : 215 - 238
  • [27] Percutaneous coronary intervention in patients with atrial fibrillation.: Antithrombotic therapy and baseline clinical characteristics analysis
    Ruiz-Nodar, J. M.
    Brouzet, T. A.
    Hurtado, J.
    Valencia, J.
    Jimeno, J. R.
    Pineda, J.
    Valdes, M.
    Sogorb, F.
    Lip, G. Y. H.
    Marin, F.
    CIRCULATION, 2008, 118 (12) : E279 - E279
  • [28] Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence?
    Ancedy, Yann
    Lecoq, Coralie
    Saint Etienne, Christophe
    Ivanes, Fabrice
    Angoulvant, Denis
    Babuty, Dominique
    Lip, Gregory Y. H.
    Fauchier, Laurent
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 203 : 987 - 994
  • [29] Triple vs. Dual Antithrombotic Therapy In Patients With Atrial Fibrillation And Acute Coronary Syndromes: The AVIATOR Registry
    Christodoulidis, Georgios
    Mennuni, Marco G.
    Sartori, Samantha
    Baber, Usman
    Dangas, George
    Sharma, Samin
    Kini, Annapoorna
    Tamburino, Corrado
    Chieffo, Alaide
    Colombo, Antonio
    Presbitero, Patrizia
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B139 - B139
  • [30] Impact of antithrombotic strategy in patients with atrial fibrillation and acute coronary syndrome
    Rio, P.
    Nogueira, M.
    Labandeiro, J.
    Pereira-Da-Silva, T.
    Timoteo, A.
    Fiarresga, A.
    Ramos, R.
    Cacela, D.
    De Sousa, L.
    Cruz Ferreira, R.
    EUROPEAN HEART JOURNAL, 2013, 34 : 246 - 246
12345